» Authors » Junichi Shoda

Junichi Shoda

Explore the profile of Junichi Shoda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 99
Citations 1870
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sato T, To K, Sakurai F, Chihara K, Warabi E, Isobe T, et al.
Exp Anim . 2025 Jan; PMID: 39864840
Unbalanced redox homeostasis leads to the production of reactive oxygen species and exacerbates inflammatory bowel disease. To investigate the role of the transcription factor Nrf2, a major antioxidative stress sensor,...
2.
Oshida N, Oh S, Kim B, Miura I, Hasegawa N, Komine S, et al.
J Obes Metab Syndr . 2024 May; 33(2):143-154. PMID: 38735655
Background: Muscle-liver crosstalk plays an important role in the development and progression of non-alcoholic fatty liver disease (NAFLD). The measurement of muscle echo-intensity during ultrasonography is a real-time, non-invasive method...
3.
Chihara K, Okada K, Uchida F, Miura I, Komine S, Warabi E, et al.
PLoS One . 2023 Oct; 18(10):e0291880. PMID: 37862331
Lipopolysaccharide (LPS) derived from Porphyromonas gingivalis (P.g.), which causes periodontal disease, contributes to the development of non-alcoholic steatohepatitis (NASH). We investigated the role of Nrf2, an antioxidative stress sensor, in...
4.
To K, Okada K, Watahiki T, Suzuki H, Tsuchiya K, Tokushige K, et al.
Cancer Med . 2023 Sep; 12(19):19423-19437. PMID: 37732511
Background: The nuclear factor E2-related factor 2-Kelch-like Ech-associated protein (NRF2-KEAP1) pathway is a major cellular defense mechanism against oxidative stress. However, the role of NRF2-KEAP1 signaling in the development of...
5.
Fujita N, Yasuda I, Endo I, Isayama H, Iwashita T, Ueki T, et al.
J Gastroenterol . 2023 Jul; 58(9):801-833. PMID: 37452855
The Japanese Society of Gastroenterology first published evidence-based clinical practice guidelines for cholelithiasis in 2010, followed by a revision in 2016. Currently, the revised third edition was published to reflect...
6.
Yabe Y, Chihara K, Oshida N, Kamimaki T, Hasegawa N, Isobe T, et al.
Nutrients . 2023 Jun; 15(12). PMID: 37375668
The incidence of non-obese non-alcoholic fatty liver disease (NAFLD), characterized by the presence of a fatty liver in individuals with a normal body mass index, is on the rise globally....
7.
Oh S, Kim E, Shoda J
Front Physiol . 2023 May; 14:1204581. PMID: 37234423
No abstract available.
8.
Miura I, Okada K, Ishii A, Warabi E, Watahiki T, To K, et al.
Front Physiol . 2022 Nov; 13:993995. PMID: 36439272
Obesity is a risk factor for many diseases because it leads to a reduction in skeletal muscle mass and promotes insulin resistance. -knockout mice are a model of metabolic syndrome;...
9.
Watahiki T, Okada K, Miura I, To K, Tanaka S, Warabi E, et al.
Antioxidants (Basel) . 2022 Oct; 11(10). PMID: 36290662
Oxidative stress (OS) contributes to nonalcoholic steatohepatitis (NASH) and hepatocarcinogenesis. We investigated whether antioxidative self-assembling nanoparticles (SMAPoTN) could reduce the development of NASH and hepatocellular carcinoma (HCC) in p62/Sqstm1 and...
10.
Yamanashi Y, Takada T, Tanaka Y, Ogata Y, Toyoda Y, Ito S, et al.
Biomed Pharmacother . 2022 Oct; 156:113877. PMID: 36270257
Background: Dietary oxysterols are believed to be associated with the progression of non-alcoholic fatty liver disease (NAFLD). However, the molecular basis of the association between dietary oxysterols and NAFLD is...